NO943811L - T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia - Google Patents

T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia

Info

Publication number
NO943811L
NO943811L NO943811A NO943811A NO943811L NO 943811 L NO943811 L NO 943811L NO 943811 A NO943811 A NO 943811A NO 943811 A NO943811 A NO 943811A NO 943811 L NO943811 L NO 943811L
Authority
NO
Norway
Prior art keywords
amb
peptides
allergens
cell epitopes
artemisiifolia
Prior art date
Application number
NO943811A
Other languages
English (en)
Norwegian (no)
Other versions
NO943811D0 (no
Inventor
Mei-Chang Kuo
Richard D Garman
Julia L Greenstein
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Publication of NO943811D0 publication Critical patent/NO943811D0/no
Publication of NO943811L publication Critical patent/NO943811L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO943811A 1992-04-09 1994-10-07 T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia NO943811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86667992A 1992-04-09 1992-04-09
PCT/US1993/003156 WO1993021321A2 (fr) 1992-04-09 1993-04-06 EPITOPES DE LYMPHOCYTES T DES PRINCIPAUX ALLERGENES D'$i(AMBROSIA ARTEMISIIFOLIA)

Publications (2)

Publication Number Publication Date
NO943811D0 NO943811D0 (no) 1994-10-07
NO943811L true NO943811L (no) 1994-12-06

Family

ID=25348157

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943811A NO943811L (no) 1992-04-09 1994-10-07 T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia

Country Status (12)

Country Link
EP (2) EP0770681A3 (fr)
JP (1) JPH07507924A (fr)
KR (1) KR950700991A (fr)
AU (1) AU685392B2 (fr)
CA (1) CA2117779A1 (fr)
FI (1) FI944697A7 (fr)
IL (1) IL105352A0 (fr)
MX (1) MX9302024A (fr)
NO (1) NO943811L (fr)
NZ (1) NZ252013A (fr)
WO (1) WO1993021321A2 (fr)
ZA (1) ZA932530B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU748104B2 (en) * 1994-09-02 2002-05-30 Merck Patent Gmbh Peptide compositions capable of down regulating an antigen specific immune response
EP0783322A1 (fr) * 1994-09-02 1997-07-16 Immunologic Pharmaceutical Corporation Compositions peptidiques pouvant reguler a la baisse une reponse immunitaire specifique a un antigene
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
AU4146796A (en) * 1994-10-27 1996-05-23 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
US6737406B1 (en) 1996-03-21 2004-05-18 Circassia, Ltd. Cryptic peptides and method for their identification
WO2001077353A2 (fr) * 2000-04-05 2001-10-18 Syngenta Participations Ag Proteines therapeutiquement actives dans des vegetaux
EP1958645A1 (fr) * 2007-02-13 2008-08-20 Biomay AG Peptides dérivés du allergène majeur de l'ambrosie (Ambrosia artemisiifolia) et leur utilisation
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
ES2378870T5 (es) * 2008-08-15 2016-02-03 Circassia Limited Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía
EP2331124A1 (fr) 2008-08-15 2011-06-15 Circassia Limited Peptide de l antigène des cellules t d allergène destiné à stimuler la production d il-10
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
CA2839832C (fr) * 2011-06-27 2018-08-28 Anergis S.A. Peptides contigus se chevauchant destines au traitement de l'allergie au pollen d'ambroisie
WO2017179025A1 (fr) * 2016-04-15 2017-10-19 Alk-Abelló A/S Polypeptides épitopiques d'allergènes de pollen d'ambroisie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011293A1 (fr) * 1989-03-17 1990-10-04 Immulogic Pharmaceutical Corporation Proteines allergenes tirees de l'ambrosie et utilisations de ces proteines

Also Published As

Publication number Publication date
WO1993021321A2 (fr) 1993-10-28
AU4046293A (en) 1993-11-18
ZA932530B (en) 1993-10-28
WO1993021321A3 (fr) 1994-02-03
EP0770681A3 (fr) 1997-06-04
NO943811D0 (no) 1994-10-07
EP0770681A2 (fr) 1997-05-02
KR950700991A (ko) 1995-02-20
MX9302024A (es) 1994-07-29
NZ252013A (en) 1996-08-27
JPH07507924A (ja) 1995-09-07
FI944697L (fi) 1994-12-07
FI944697A7 (fi) 1994-12-07
FI944697A0 (fi) 1994-10-07
IL105352A0 (en) 1993-08-18
EP0636180A1 (fr) 1995-02-01
AU685392B2 (en) 1998-01-22
CA2117779A1 (fr) 1993-10-28

Similar Documents

Publication Publication Date Title
ATE444360T1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
NO943811L (no) T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia
Goyert et al. Isolation of I–A subregion-like molecules from subhuman primates and man
JPH09501159A (ja) 合成多重縦列反復ムチンおよびムチン様ペプチド、並びにそれらの利用
EP0909814A3 (fr) Utilisation de protéine kinases pour le diagnostic et le traitement de la Maladie d'Alzheimer
EP0905518A1 (fr) Peptides spécifiques pour cellules sensibles au gluten et utilisation de ceux-ci
DK1672368T3 (da) Diagnostisk og terapeutisk epitop
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
NO953571L (no) T-celle-epitoper av vanlig raigress-pollen allergen
Hill et al. A chemical abnormality in haemoglobin G
Leitner et al. A mimotope defined by phage display inhibits IgE binding to the plant panallergen profilin
NO960858L (no) Anvendelser av myelin - oligodendrocyt-glykoprotein og peptid-deler derav i metoder i forbindelse med autoimmunsykdom
DK1025849T3 (da) Fremgangsmåder til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-antigener
US7862828B2 (en) Allergy vaccines containing hybrid polypeptides
Cervenakova et al. Failure of immunocompetitive capillary electrophoresis assay to detect disease‐specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt‐Jakob disease
SI0998556T1 (en) Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
NO960553L (no) T-celle-epitoper av raigresspollen-allergen
Zhu et al. T cell epitope mapping of ragweed pollen allergen Ambrosia artemisiifolia (Amb a 5) and Ambrosia trifida (Amb t 5) and the role of free sulfhydryl groups in T cell recognition
ES2110996T3 (es) Alergeno de polen de ballico.
WO1992021697A3 (fr) Peptides diagnostiques derives d'antigenes de la m.tuberculose
DE69333709D1 (de) T-zell epitope des raygraspollen-allergens
ES2930857T3 (es) Origen molecular de la alergia
EP1436320A4 (fr) Epitopes de lymphocytes t de l'allergene cyn d1 provenant de pollen de cynodon
CA2123694A1 (fr) Peptides et anticorps pour le traitement de l'arthrite rhumatoide
NO962596L (no) Nytt tumorsupressorgen